We are live on ! Find out more
VRTX icon

Vertex Pharmaceuticals
VRTX

376 hedge funds and large institutions have $17.1B invested in Vertex Pharmaceuticals in 2013 Q2 according to their latest regulatory filings, with 376 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

46% more call options, than puts

Call options by funds: $419M | Put options by funds: $287M

Holders
376
Holders Change
+376
Holders Change %
–
% of All Funds
12.27%
Holding in Top 10
7
Holding in Top 10 Change
+7
Holding in Top 10 Change %
% of All Funds
0.23%
New
376
Increased
–
Reduced
–
Closed
–
Calls
$419M
Puts
$287M
Net Calls
+$131M
Net Calls Change
+$131M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Capital Fund Management (CFM)
226
Capital Fund Management (CFM)
France
$1.18M +$1.09M +14,791 New
SIA
227
Sit Investment Associates
Minnesota
$1.14M +$1.05M +14,200 New
Nordea Investment Management
228
Nordea Investment Management
Sweden
$1.13M +$1.04M +14,148 New
MPA
229
Marvin & Palmer Associates
Delaware
$1.1M +$1.02M +13,800 New
WBC
230
Westpac Banking Corp
Australia
$1.07M +$1.11M +15,039 New
TG
231
TCW Group
California
$1.04M +$955K +12,973 New
Jane Street
232
Jane Street
New York
$1.01M +$929K +12,609 New
PP
233
Paloma Partners
Connecticut
$1.01M +$927K +12,591 New
SCM
234
Stux Capital Management
New York
$961K +$884K +12,000 New
WC
235
Woodstock Corp
Massachusetts
$961K +$884K +12,003 New
JIC
236
Johnson Investment Counsel
Ohio
$955K +$879K +11,935 New
CWM
237
Concert Wealth Management
California
$912K +$840K +11,403 New
CCM
238
Cupps Capital Management
Illinois
$884K +$814K +11,053 New
JG
239
Jefferies Group
New York
$861K +$792K +10,758 New
Los Angeles Capital Management
240
Los Angeles Capital Management
California
$858K +$789K +10,713 New
CIC
241
Canal Insurance Company
South Carolina
$854K +$788K +10,696 New
KIA
242
Kopp Investment Advisors
Minnesota
$848K +$780K +10,588 New
CIBC Asset Management
243
CIBC Asset Management
Ontario, Canada
$847K +$779K +10,577 New
WSA
244
Wall Street Associates
California
$839K +$771K +10,474 New
Toronto Dominion Bank
245
Toronto Dominion Bank
Ontario, Canada
$839K +$771K +10,475 New
GI
246
GLG Inc
New York
$834K +$769K +10,443 New
DADC
247
D.A. Davidson & Co
Montana
$829K +$765K +10,385 New
N
248
Natixis
France
$799K +$736K +10,000 New
HC
249
Highmount Capital
New York
$777K +$714K +9,700 New
William Blair & Company
250
William Blair & Company
Illinois
$764K +$705K +9,570 New
8 9
10
11 12

VRTX Hedge Fund Activity: Q2 2013 in Review

376 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Vertex Pharmaceuticals (VRTX) for Q2 2013, worth a combined $17.1B.

Buyers outnumbered sellers: 376 funds opened new VRTX positions and 0 closed out — a net gain of 376 holders — while 0 added to existing stakes and 0 trimmed.

  • 376 institutional investors held Vertex Pharmaceuticals (VRTX) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $17.1B of Vertex Pharmaceuticals stock for Q2 2013.
  • 376 funds opened new Vertex Pharmaceuticals positions in Q2 2013 and 0 closed out, a net change of +376 holders.

Based on aggregated 13F filings for Q2 2013.